Redcliffe Labs, the purpose-driven pan-India omnichannel diagnostics service provider, announced a strategic leadership transition. Its Founder, Aditya Kandoi, has stepped in as Chief Executive Officer (CEO), and Dheeraj Jain has taken up the role of Chairman of the Board.
Under Aditya’s leadership, Redcliffe Labs has an ambitious expansion strategy that will extend the company’s reach to Tier 2, Tier 3, and Tier 4 cities and beyond.
In the new position, Dheeraj Jain leads the Board of Directors as Chairman, providing strategic oversight, facilitating governance, and ensuring effective board management.
Aditya Kandoi, CEO of Redcliffe Labs, said, “At Redcliffe Labs, we are committed to redefining the accessibility of quality healthcare by focusing on innovation, operational excellence, and patient-centric solutions. Our vision goes beyond delivering diagnostics—we aim to empower every individual with the quality diagnostics to take charge of their holistic health and well-being. Together with our highly skilled and self-driven team, we will work tirelessly to bridge the healthcare gap and set new standards in the industry. It is a step towards contributing to a healthier and stronger Bharat.”
Dheeraj Jain, Chairman of Redcliffe Labs, said, “Redcliffe Labs has always been driven by a vision to make healthcare accessible and impactful. After being its CEO for 6 years since its inception, I am delighted to welcome my Co-founder Aditya Kandoi to take charge as its CEO, whose exceptional execution expertise and visionary approach will be instrumental in taking Redcliffe Labs to new heights and setting benchmarks for healthcare standards nationwide & even globally. Together, we will be steering the organization through a phase of transformative growth while upholding our values of innovation and customer excellence. With a passionate leadership team and a shared commitment to delivering top medical quality, we will redefine healthcare standards in India.”
